ArticleThe Journal of clinical investigation2004

Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance.

Zhiya Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.